Key Highlights

  • AEVEX (NASDAQ:AVEX) closed up 13.44% on Thursday, November 12, 2026, after trading up as much as 27.26% in the morning.
  • The company raised its 2026 Revenue outlook to USD 820 million to USD 840 million from USD 700 million to USD 720 million.
  • Third quarter revenue was USD 189.7 million, up 56.5%, with a net loss of USD 16.8 million.
  • The advance extends a rally in the shares, in a session when the S&P 500 fell 0.35% and industrials were down 0.89%.

A Large Increase in Guidance

AEVEX reported third quarter revenue of USD 189.7 million, an increase of 56.5% from a year earlier. Management lifted its 2026 revenue outlook to USD 820 million to USD 840 million, compared with a previous range of USD 700 million to USD 720 million, an increase of about 17% at the midpoint. A raise of that size within one quarter is uncommon and signals that demand, contract awards and delivery schedules are running ahead of the plan. The stock was up 12.20% before 7 AM Eastern, up 17.52% at 10:05 AM, up 27.26% at 11:02 AM and closed up 13.44%, which shows that buyers pushed it very high early before profit taking narrowed the gain. The company reported a net loss of USD 16.8 million, which investors largely set aside given the growth. Companies that raise guidance this much often do so after winning large programs, and the market will look for details on which contracts drove the change. The path from a 56.5% growth rate to full year revenue of USD 820 million to USD 840 million implies a strong fourth quarter as well, which supports the view that momentum is continuing.

Why Defense Technology Is in Demand

AEVEX operates in airborne intelligence, surveillance and reconnaissance, drones and related defense technology, areas that have attracted rising budgets as governments focus on unmanned systems, sensors and fast delivery. Conflicts and tensions in several regions have shown the value of drones and persistent surveillance, and procurement programs have moved faster in these categories. That environment supports revenue growth and gives the company a Backlog that can support guidance. Strong growth in the quarter of 56.5% suggests that the company is winning work and converting it into revenue. The strength of the stock also reflects that it is a recent public company, so each quarter adds to its track record and can reset expectations. Defense and aerospace were weaker elsewhere in the market on Thursday, with industrials down 0.89%, which made the move stand out. Customers include defense and intelligence agencies, which tend to buy through multi-year programs, so wins can support revenue for several quarters. The company also benefits from the broader push by militaries to field more low-cost uncrewed systems alongside traditional platforms.

What Investors Weigh Now

The positive points are rapid growth, the guidance increase and the favorable spending environment. The risks include a net loss, dependence on government contracts, timing of awards, Supply chain constraints and a stock that has already rallied. When a stock rises sharply on two consecutive days, any sign of slower orders can trigger sharp reversals. Rising interest rates, including a 10-year Yield near 5.10%, add pressure to growth names. Investors will watch the pace of contract wins, the path to profitability, margins on the new work and how much of the raised revenue is already contracted. The company's next report will show whether the stronger outlook is secure or whether growth is being pulled forward. Investors should also consider that a net loss alongside rapid growth means the Business is still investing heavily, and gross Margin trends will be important to judge quality.

Where Things Stand

AEVEX raised its 2026 revenue outlook by about 17% at the midpoint and the stock rose 13.44%. The next signals are new contract awards, margin progress and the fourth quarter report. Investors will want evidence that growth is durable and that losses narrow. The size of the guidance increase makes the fourth quarter report an important checkpoint.